September 24th, 2023

On Thursday, September 28, a number of companies are scheduled to announce their financial results, including: Accenture plc (NYSE: ACN), a global consulting and professional services firm, is set to announce its fourth-quarter and full-year fisca. Read more

September 24th, 2023

On Wednesday, September 27, several companies are poised to announce their financial results: Concentrix Corporation (Nasdaq: CNXC), a global leader in customer engagement services, is scheduled to disclose its fiscal third-quarter 2023 financial . Read more

September 23rd, 2023

Several notable companies are set to reveal their financial results on Wednesday, September 27, including: Micron Technology, Inc. (Nasdaq: MU), a technology company known for its innovative semiconductor solutions, will disclose its fourth-quarte. Read more

September 23rd, 2023

On Tuesday, September 26, several companies are set to reveal their financial performance, including: TD SYNNEX Corporation (NYSE: SNX), a corporation specializing in IT distribution and services, is scheduled to announce its third-quarter fiscal . Read more

September 23rd, 2023

On Tuesday, September 26, several companies are scheduled to release their financial results, including: Costco Wholesale Corporation (Nasdaq: COST), a retail giant known for its warehouse club stores, will report its fourth-quarter fiscal 2023 fi. Read more

September 23rd, 2023

Fluor Marine Propulsion LLC, a subsidiary of Fluor Corporation (NYSE: FLR), has secured a significant cost-plus-fixed-fee contract modification worth $1,362,922,002. This modification exercise is for fiscal year 2024 options related to Naval Nuclear . Read more

September 22nd, 2023

The October 4 event will focus on impact of generative AI on creative fields Washington D.C. / CRWE PRESS RELEASE / September 22, 2023 -  The Federal Trade Commission staff will be hosting a virtual roundtable discussion on October 4, 20. Read more

September 22nd, 2023

Astellas Pharma Inc. and Seagen Inc. (Nasdaq: SGEN) have reported promising results from the Phase 3 EV-302 clinical trial (KEYNOTE-A39) for PADCEV (enfortumab vedotin-ejfv) combined with Merck & Co., Inc.'s (NYSE: MRK) KEYTRUDA (pembrolizumab) versu. Read more

September 22nd, 2023

The European Commission has re-imposed a fine of approximately €376.36 million on Intel Corporation (Nasdaq: INTC) for anticompetitive practices in the x86 central processing unit (CPU) market dating back to 2009. These practices involved condit. Read more

September 22nd, 2023

The UK's Competition and Markets Authority (CMA) has indicated that the sale of Activision Blizzard, Inc.'s (Nasdaq: ATVI) cloud gaming rights to Ubisoft Entertainment SA has substantially addressed previous concerns, potentially paving the way for t. Read more